NSG

Tufin Enhances Visibility and Control Capabilities, Streamlining Management of Network and Cloud Security From a Single Platform

Retrieved on: 
Tuesday, March 19, 2024
Data Management, Security, Technology, Other Technology, Software, Networks, Internet, Cloud, Microsoft, GCP, Automation, Microsoft Azure, ROI, Palo Alto Networks, Policy, Philosophy, PCI DSS, Panorama, PCI, Computer security, API, Google Cloud Platform, Product management, Zero trust security model, NSG, Online shopping

Tufin® , the leader in network and cloud security policy automation, today announced the release of Tufin Orchestration Suite (TOS) version R24-1 .

Key Points: 
  • Tufin® , the leader in network and cloud security policy automation, today announced the release of Tufin Orchestration Suite (TOS) version R24-1 .
  • The latest additions to Tufin’s solution enhance customers’ ability to manage cloud security controls from a centralized interface, making security policy management more effective.
  • With TOS R24-1, Tufin enables complete visibility across today’s complex hybrid enterprise networks, helping teams maintain security and compliance.
  • “Security teams need tools to deliver the same visibility and management capabilities across on-premise, cloud, and hybrid networks.

ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State

Retrieved on: 
Tuesday, March 5, 2024
Radiology, Surgery, Oncology, Health, Medical Devices, Robotics, Hospitals, Technology, AVM, TK, Neoplasm, Multimedia, MD, Isotope, NSG, Radiosurgery, Radiation, Spine, Stanford University, Chiari malformation, ZAP, Patient, Brain, Trigeminal neuralgia, SRS, Radiation therapy, Stereotactic surgery, Medical imaging

NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania.

Key Points: 
  • NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania.
  • System installation is expected to begin in July, with first patient treatments estimated to commence before the end of the year.
  • “As a procedure with no incisions and no pain, ZAP-X radiosurgery treats patients in what often requires only a single brief outpatient visit.
  • This novel approach aims to maximally safeguard healthy brain tissue and preserve patient cognitive function.

ePlus Reports Third Quarter and First Nine Months Financial Results

Retrieved on: 
Tuesday, February 6, 2024
Growth, Consolidated, IT service management, GAAP, Environment, Security operations center, Investment, Total, Partner, Acquisition, NSG, EPlus, Webcast, Bank

Net sales increased 6.0% to $1,670.8 million; technology business net sales increased 6.5% to $1,631.8 million; services revenues increased 8.9% to $213.2 million.

Key Points: 
  • Net sales increased 6.0% to $1,670.8 million; technology business net sales increased 6.5% to $1,631.8 million; services revenues increased 8.9% to $213.2 million.
  • ePlus inc. (NASDAQ:  PLUS), a leading provider of technology and financing solutions, today announced financial results for the three months and nine months ended December 31, 2023.
  • As we enter our fiscal fourth quarter, customer purchasing trends have improved, which supports the lower end of our fiscal 2024 financial guidance range," said Mark Marron, President and CEO of ePlus.
  • For the third quarter ended December 31, 2023, as compared to the third quarter ended December 31, 2022:
    Consolidated net sales decreased 18.4% to $509.1 million, from $623.5 million.

Observer Platform Innovations From VIAVI Enhance Visibility Across Users, Applications and the Cloud

Retrieved on: 
Tuesday, January 9, 2024
HTTPS, Observer, Unified communications, UC, Microsoft, EUE, DPI, Partnership, Network, Risk, NetOps, Deep packet inspection, AWS, KPI, NSG, Organization, HTTP

CHANDLER, Ariz., Jan. 9, 2024 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced significant enhancements to the Observer Platform allowing IT teams to further maximize network availability, productivity and compliance.

Key Points: 
  • CHANDLER, Ariz., Jan. 9, 2024 /PRNewswire/ -- Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today announced significant enhancements to the Observer Platform allowing IT teams to further maximize network availability, productivity and compliance.
  • With a majority of enterprise applications hosted in the cloud, fewer than 1% of organizations say they are satisfied with network visibility.
  • Problem domain isolation – pinpointing issues across network, server, application, or client domains ­– remains one of the biggest challenges for NetOps teams.
  • The latest Observer release, v18.17, addresses these challenges to improve reliability of networks in meeting organizational objectives.

NativeSeed Group & Great Valley Seed Form Strategic Alliance to Supply Native Seed for Unprecedented Demand in California

Retrieved on: 
Monday, December 11, 2023
GVS, Strategic alliance, Commitment, Seed, NSG, National academy, Conservation, Partnership, Knowledge, Agriculture, Renewable energy, Airline, Silviculture

CARPINTERIA, Calif., Dec. 11, 2023 /PRNewswire/ -- NativeSeed Group (NSG) and Great Valley Seed Company (GVS), renowned commercial native seed production and conservation entities, are excited to announce a significant strategic alliance.

Key Points: 
  • CARPINTERIA, Calif., Dec. 11, 2023 /PRNewswire/ -- NativeSeed Group (NSG) and Great Valley Seed Company (GVS), renowned commercial native seed production and conservation entities, are excited to announce a significant strategic alliance.
  • NativeSeed Group and Bowles Farm are committed to delivering on conservation initiatives in California.
  • Extensive Wildland Seed Collection Network: Complementing production efforts, NativeSeed Group brings to the table the largest network of wildland seed collection capabilities in California and the Western United States.
  • For more information about this alliance and its impact on conservation initiatives, please contact Julia Michaels at NativeSeed Group ( [email protected] ) or Doug Iten at Great Valley Seed ( [email protected] ).

ePlus Reports Second Quarter and First Half Financial Results

Retrieved on: 
Tuesday, November 7, 2023
Cloud, EPlus, EBITDA, GAAP, Acquisition, Maintenance, Security operations center, IT service management, Information security operations center, Environment, Growth, EPS, Webcast, NSG, Total, Service, NetApp, Video game, Holding company, Fossil fuel, Aquaculture, Bookkeeping, Bank, Network equipment provider, Textile, Cryptocurrency, Airline, Retail, Real estate, Life insurance

HERNDON, Va., Nov. 7, 2023 /PRNewswire/ --

Key Points: 
  • ePlus inc. (NASDAQ:  PLUS), a leading provider of technology and financing solutions, today announced financial results for the three months and six months ended September 30, 2023.
  • "Our second quarter financial results underscore the advantages of our diversified solutions and end markets," said Mark Marron, president and CEO of ePlus.
  • For the second quarter ended September 30, 2023, as compared to the second quarter ended September 30, 2022:
    Consolidated net sales increased 19.0% to $587.6 million, from $493.7 million.
  • "Despite an uncertain macroeconomic environment, ePlus generated strong financial results through the first half of this fiscal year.

Coeptis Therapeutics Announces Research Demonstrating the Potential of SNAP-CAR T-cells to Reduce Tumor Burden and Growth in HER2 and CD20 Expressing Cancers Will be Presented at SITC 2023

Retrieved on: 
Tuesday, October 31, 2023
EGFR, Society for Immunotherapy of Cancer, Neoplasm, CAR, Ovarian cancer, Assistant, CD20, HER2, University, Research, CD69, Mouse, SNAP, SITC, Immunotherapy, Poster, Division, San Diego Convention Center, Cancer, University of Pittsburgh, LAMP1, Leukemia, NSG, Epitope, Society, Therapy, Immunology, Toxic shock syndrome toxin-1, Mobile phone, Vaccine

WEXFORD, Pa., Oct. 31, 2023 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced that research demonstrating the potential of the SNAP-CAR T-cell platform to target multiple antigens, including HER2 and CD20, through combinatorial use of different adaptors will be the subject of a poster presentation at the Society for Immunotherapy of Cancer's 38th Annual Meeting (SITC 2023). SITC 2023 is being held Nov. 1–5, 2023, at San Diego Convention Center in San Diego. 

Key Points: 
  • SITC 2023 is being held Nov. 1–5, 2023, at San Diego Convention Center in San Diego.
  • Further, in another leukemia model targeting the CD20 antigen, SNAP-CAR T cells showed significant inhibition of tumor growth.
  • "While still early in its development, we continue to see vast potential for the SNAP-CAR platform for treating both liquid and solid tumor malignancies."
  • "The data being presented at SITC 2023 encapsulates the groundbreaking research being conducted at the University of Pittsburgh, which demonstrates the potential of SNAP-CAR T-cells to reduce tumor burden and tumor growth in numerous cancers, including HER2-expressing and CD20-expressing cancers," said Dave Mehalick, President and CEO of Coeptis Therapeutics.

Fire Protection System Testing, Inspection, And Certification (TIC) Market worth $633 million by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, September 27, 2023
Smoke, Medicine, Power source, Intertek, Engineering, Construction, Lithium battery, NSG, Fire, SAI, Water supply, TIC, SGS, UL, Final good, Organization, HVAC, Wildfire, API, DNV, Water, UL LLC, Bureau Veritas, Region, Safety, Automation, Medical device, Video game, Certification, Inspection, Maintenance, Mining, Food

Further bolstering the fire protection system TIC market are expanding fire safety requirements in emerging economies, heightened awareness of fire safety, and a growing need for system maintenance and testing services.

Key Points: 
  • Further bolstering the fire protection system TIC market are expanding fire safety requirements in emerging economies, heightened awareness of fire safety, and a growing need for system maintenance and testing services.
  • Consequently, TIC providers offering innovative solutions are poised for success in this evolving market.
  • By service type, the certification service records the highest growth rate during the forecast period.
  • During the forecast period, the Fire Protection System Testing, Inspection, and Certification (TIC) industry is expected to witness a substantial market share held by the sprinkler system segment.

Fire Protection System Testing, Inspection, And Certification (TIC) Market worth $633 million by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, September 27, 2023
Smoke, Medicine, Power source, Intertek, Engineering, Construction, Lithium battery, NSG, Fire, SAI, Water supply, TIC, SGS, UL, Final good, Organization, HVAC, Wildfire, API, DNV, Water, UL LLC, Bureau Veritas, Region, Safety, Automation, Medical device, Video game, Certification, Inspection, Maintenance, Mining, Food

Further bolstering the fire protection system TIC market are expanding fire safety requirements in emerging economies, heightened awareness of fire safety, and a growing need for system maintenance and testing services.

Key Points: 
  • Further bolstering the fire protection system TIC market are expanding fire safety requirements in emerging economies, heightened awareness of fire safety, and a growing need for system maintenance and testing services.
  • Consequently, TIC providers offering innovative solutions are poised for success in this evolving market.
  • By service type, the certification service records the highest growth rate during the forecast period.
  • During the forecast period, the Fire Protection System Testing, Inspection, and Certification (TIC) industry is expected to witness a substantial market share held by the sprinkler system segment.

Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation

Retrieved on: 
Thursday, September 7, 2023
Infection, Rat, Serum, Biotechnology, Liver, NSG, Mutation, Toxicity, SERPINA1, Inflammation, Lung, Piz, AATD, HIV disease progression rates, Pizzicato, Mouse, AAT, LNP, Dietary supplement, Pharmaceutical industry, Vaccine, Beam

The data are featured in an oral presentation titled “BEAM-302: Targeting AATD Liver and Lung Disease with Base Editing” at the Alpha-1 Antitrypsin Deficiency 2023 Meeting in Naples, Italy.

Key Points: 
  • The data are featured in an oral presentation titled “BEAM-302: Targeting AATD Liver and Lung Disease with Base Editing” at the Alpha-1 Antitrypsin Deficiency 2023 Meeting in Naples, Italy.
  • “In today’s presentation, we shared – for the first time – a full summary of preclinical in vivo data for BEAM-302, our lead candidate for the potential treatment of AATD.
  • BEAM-302 is a liver-targeting lipid-nanoparticle (LNP) formulation of base editing reagents designed to precisely correct the PiZ mutation, a single-letter genetic error.
  • Beam plans to submit a regulatory application for authorization to initiate clinical trials of BEAM-302 in the first quarter of 2024.